
Tulac100 ml
Eskayef Bangladesh Ltd.
Established / FDA-approved use Treatment of chronic constipation : Lactulose is indicated for patients with chronic idiopathic constipation who have not responded adequately to diet and lifestyle…
Lactulose is not an antibiotic and has no role in treating infections.
Usual dose: 15–30 mL (10–20 g) of Lactulose oral solution once daily, which may be increased up to 60 mL/day if required. A bowel movement is usually produced within 24–48 hours; the dose can then be titrated to maintain 1–2 soft stools per day.
Formal safety and effectiveness data for constipation in children have not been established in the manufacturer's labeling; however, Lactulose is commonly used off-label under medical supervision, typically dosed by age/weight and titrated to a soft, comfortable stool pattern. Pediatric dosing should always be individualized and supervised by a physician.
| Regimen | Typical dose |
|---|---|
| Initial/titration | 30–45 mL (20–30 g) orally, 3–4 times daily, or 30–45 mL every 1–2 hours until laxation occurs, then adjust |
| Maintenance | Dose titrated (usually 30–45 mL, 2–4 times daily) to achieve 2–3 soft, formed stools per day |
| Rectal (if oral not possible) | A retention enema of Lactulose solution diluted in water, given under medical supervision, may be used in patients unable to take oral therapy |
Dosing for hepatic encephalopathy is higher and more frequent than for simple constipation and must be individually titrated and monitored by a physician; it is not a fixed regimen for self-adjustment by the patient.
No dose adjustment is required for renal impairment because systemic absorption of Lactulose is minimal. Lactulose is, in fact, the primary treatment used in patients with hepatic impairment (for hepatic encephalopathy); electrolytes should be monitored with prolonged or high-dose use in this population.
Common (especially at the start of therapy, usually transient and dose-related): abdominal bloating, flatulence, belching, and abdominal cramping.
Less common: nausea, vomiting, and diarrhea, particularly with excessive dosing.
Uncommon/with excessive or prolonged use: electrolyte imbalance (e.g., low potassium, low sodium) related to fluid loss from diarrhea — see Precautions and Warnings.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.